Now we can offer LAP-BAND® as a long-term weight loss option to Connecticut patients who are 50-70 pounds overweight.
Trumbull, CT (Vocus/PRWEB) February 23, 2011
For those people in Connecticut who suffer from obesity but are less than 100 pounds overweight, long-term weight loss often achieved with minimally invasive weight-loss surgery is now a viable option. On February 16, 2011, the LAP-BAND® Adjustable Gastric Banding System, previously only available to morbidly obese adults with a BMI of 40 or more or a BMI of 35 or more with at least one obesity-related condition, was approved by the FDA for obese adults who have a BMI of 30 or more and at least one obesity-related health problem.
The FDA approval to expand the use of the LAP-BAND® System with lower weight requirements was based on a review of the 24-month data from the five-year study to determine the safety and effectiveness of the LAP-BAND® System as a treatment for obesity in adults with a BMI between 30 and 40. Dr. Timothy Ehrlich, Director of Metabolic and Bariatric Surgery at Griffin Hospital and an experienced bariatric surgeon in Connecticut, treated 30 of the 149 patients enrolled in the study.
Although the LAP-BAND® System is not for everyone, those people with a BMI of 30, or approximately 50 to 70 pounds overweight, can now benefit from significant weight loss that can be achieved with bariatric surgery. Over 20% of the Connecticut population falls into this category, according to the Centers for Disease Control and Prevention (CDC). The new LAP-BAND® System indication includes obese patients with a related health condition, such as heart disease, Type 2 diabetes, high blood pressure, sleep apnea and joint problems, who have failed more conservative weight-loss therapies, such as diet and exercise and pharmacotherapy.
“We are thrilled to have participated in the study that expanded the use of the LAP-BAND® System to the lower BMI patients,” said Dr. Timothy Ehrlich. “These patients still carry over 50 pounds of excess weight, which often comes with diseases such as hypertension, infertility/PCOS and Type 2 diabetes, but until now they did not have a long-term weight loss option. Now we can offer LAP-BAND® surgery to help them lose weight and improve, or even resolve, most of these conditions. For example, surgical weight loss could prevent a degenerative disease like Type 2 diabetes at an early stage from worsening over time.”
Lisa Molholt, a Milford, Connecticut, resident and low BMI study participant, lost over 110 pounds in 2 years after her LAP-BAND® surgery with Dr. Ehrlich. She also lost her worsening knee problems, avoided a major joint replacement operation,and regained her health and her life. “The LAP-BAND® is the most valuable tool in my ‘tool shed’ for showing me what I can accomplish and keeping me on track,” she says.
About Dr. Timothy Ehrlich
Headquartered in Trumbull, Connecticut, Dr. Timothy Ehrlich is the founder of Ehrlich Bariatrics and Director of Metabolic and Bariatric Surgery at Griffin Hospital. Dr. Ehrlich is a fellow of the American College of Surgeons and has performed over 2,000 bariatric procedures, including Roux-en-Y gastric bypass, LAP-BAND® System, and revisional weight loss surgeries. He was a primary investigator for a study conducted by Allergan, the manufacturer of the LAP-BAND® System , completing 30 procedures in patients with a BMI of at least 35 or a BMI >30 and at least one comorbid condition. Ehrlich Bariatrics offers free informational weight-loss surgery seminars weekly throughout Connecticut. To learn more, please visit http://www.ehrlichbariatrics.com or http://www.drehrlichweightloss.com, connect with Dr. Ehrlich on Twitter,or call 203-880-5000.